Current management of severe ulcerative colitis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Clinical Practice Gastroenterology &Hepatology

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ncpgasthep0687PMID 17268544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

  2006cited by this paper
• Genetics of inflammatory bowel disease: the role of the HLA complex.

  2006cited by this paper
• ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.

  2006cited by this paper
• Infliximab for Hospitalized Patients With Severe Ulcerative Colitis

  2006cited by this paper
• Hypothesis: Chemotaxis in Escherichia coli Results from Hyperstructure Dynamics

  2006cited by this paper
• Utility of cells exfoliated onto the esophagoscope as an aid in the diagnosis of esophageal carcinoma

  2005cited by this paper
• Ciclosporin use in acute ulcerative colitis: a long-term experience

  2005cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• Infliximab for induction and maintenance therapy for ulcerative colitis.

  2005cited by this paper
• Cyclosporine A for induction of remission in severe ulcerative colitis.

  2005cited by this paper
• Practice Parameters for the Surgical Treatment of Ulcerative Colitis

  2005cited by this paper
• Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats.

  2005cited by this paper
• Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

  2005cited by this paper
• Is Endoscopy Necessary for the Measurement of Disease Activity in Ulcerative Colitis?

  2005cited by this paper
• Prevention of Postoperative Abdominal Adhesions by a Novel, Glycerol/Sodium Hyaluronate/Carboxymethylcellulose-Based Bioresorbable Membrane: A Prospective, Randomized, Evaluator-Blinded Multicenter Study

  2005cited by this paper
• Leukocytapheresis (LCAP) for Management of Fulminant Ulcerative Colitis with Toxic Megacolon

  2005cited by this paper
• Endoscopic decompression in “toxic megalcolon”

  2004cited by this paper
• Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis: A Case-Control Study

  2004cited by this paper
• Predicting outcome in severe ulcerative colitis.

  2004cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2004cited by this paper
• Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

  2003cited by this paper
• Mortality in inflammatory bowel disease: peril and promise.

  2003cited by this paper
• Cytomegalovirus infection in steroid-refractory ulcerative colitis

  2003cited by this paper
• Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

  2003cited by this paper
• Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

  2003cited by this paper
• Mortality in inflammatory bowel disease: a population-based cohort study.

  2003cited by this paper
• Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials.

  2003cited by this paper
• A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management

  2003cited by this paper
• GI distension in severe ulcerative colitis

  2002cited by this paper
• Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

  2002cited by this paper
• Toxic megacolon: role of CT in evaluation and detection of complications.

  2001cited by this paper
• Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.

  2001cited by this paper
• Hyperbaric oxygen therapy for severe ulcerative colitis.

  2001cited by this paper
• Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis

  2001cited by this paper
• Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis

  2000cited by this paper
• Multiple organ dysfunction in ulcerative colitis

  2000cited by this paper
• A simple clinical colitis activity index

  1998cited by this paper
• Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis

  1998cited by this paper
• Predicting outcome in severe ulcerative colitis.

  1996cited by this paper
• Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon.

  1995cited by this paper
• Colonoscopy of acute colitis

  1994cited by this paper
• Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

  1994cited by this paper
• Toxic megacolon: the knee-elbow position relieves bowel distension.

  1993cited by this paper
• An index of disease activity in patients with ulcerative colitis.

  1992cited by this paper
• Small bowel gas in severe ulcerative colitis.

  1991cited by this paper
• Management of severe hemorrhage in ulcerative colitis.

  1990cited by this paper
• Period and generation effects on mortality from idiopathic inflammatory bowel disease

  1989cited by this paper
• Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up.

  1988cited by this paper
• Perforation of the intestine in inflammatory bowel disease. An OMGE survey.

  1988cited by this paper
• Induction of and adaptation to olsalazine induced intestinal volume load.

  1988cited by this paper
• Early recognition of toxic megacolon.

  1987cited by this paper
• Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial.

  1987cited by this paper
• Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

  1986cited by this paper
• Controlled trial of bowel rest in the treatment of severe acute colitis.

  1986cited by this paper
• Outcome of toxic dilatation in ulcerative and Crohn's colitis.

  1985cited by this paper
• Systemic corticosteroid therapy of ulcerative colitis.

  1985cited by this paper
• Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial.

  1983cited by this paper
• An Experience of Ulcerative Colitis

  1983cited by this paper
• Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis: A prospective, randomized, double-blind clinical trial

  1983cited by this paper
• Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features.

  1980cited by this paper
• Risk factors in toxic megacolon

  1980cited by this paper
• Salt-losing diarrhoea in idiopathic proctocolitis.

  1978cited by this paper
• Further experience in the treatment of severe attacks of ulcerative colitis.

  1978cited by this paper
• A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis.

  1977cited by this paper
• Blood pH: a test for assessment of severity in proctocolitis.

  1976cited by this paper
• Assessment of severity in colitis: a preliminary study.

  1975cited by this paper
• DENTAL CARIES AND SUGAR INTAKE

  1975cited by this paper
• Intensive intravenous regimen for severe attacks of ulcerative colitis.

  1974cited by this paper
• Pitfalls in the surgical management of fulminating ulcerative colitis

  1972cited by this paper
• Corticosteroid therapy in ulcerative colitis.

  1970cited by this paper
• An experience of ulcerative colitis. I. Toxic dilation in 55 cases.

  1969cited by this paper
• Definition of megacolon in colitis.

  1969cited by this paper
• FINAL REPORT ON A THERAPEUTIC TRIAL

  1955cited by this paper
• Cortisone in Ulcerative Colitis

  1954cited by this paper
• WHAT IS ULCERATIVE COLITIS

  1953cited by this paper
• ULCERATIVE COLITIS COURSE AND PROGNOSIS

  1950cited by this paper

• Revolutionizing IBD therapy: Insights into contemporary treatment strategies

  2025cites this paper
• Rosemary essential oil microemulsion prevents DSS-induced intestinal injury in mice by modulating IL-17 signaling pathway

  2024cites this paper
• Indications, modalités et résultats du traitement chirurgical de la rectocolite hémorragique en 2024

  2024cites this paper
• Future of Acute Severe Ulcerative Colitis—A Narrative Review

  2024cites this paper
• Indications, modalities, and outcomes of surgery for ulcerative colitis in 2024.

  2024cites this paper
• The Correlation between Serological Indicators and the Severity of Ulcerative Colitis

  2023cites this paper
• Consensus on controversial issues of the surgery for Crohn’s disease by Delphi method

  2023cites this paper
• Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis

  2021cites this paper
• The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients.

  2021cites this paper
• Rutin prevents inflammation-associated colon damage via inhibiting the p38/MAPKAPK2 and PI3K/Akt/GSK3β/NF-κB signalling axes and enhancing splenic Tregs in DSS-induced murine chronic colitis.

  2021cites this paper
• The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides.

  2020cites this paper
• Can red blood cell distribution width (RDW) predict clinical and endoscopic activity in ulcerative colitis patients?

  2020cites this paper
• Investigation on the function tropism of Tiaoqin and Kuqin (different specification of Scutellaria baicalensis) by comparing their curative effect on different febrile disease model.

  2020cites this paper
• The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat

  2019cites this paper
• Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?

  2019cites this paper
• Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

  2019cites this paper
• Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis.

  2019cites this paper
• Effect of Accelerated Infliximab Induction on Short‐ and Long‐term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta‐analysis

  2019cites this paper
• Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.

  2018cites this paper
• Assessment of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Ulcerative Colitis: A Retrospective Study

  2017cites this paper
• Charakterisierung eines neuen Colitis ulcerosa Modells in NOD Scid IL2Rγ Chainnull Mäusen mit humanisiertem Immunsystem

  2016influential citation
• Surgical management of inflammatory bowel disease in China: a systematic review of two decades

  2016cites this paper
• Fucoxanthin-Rich Brown Algae Extract Decreases Inflammation and Attenuates Colitis-associated Colon Cancer in Mice

  2016cites this paper
• Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

  2015cites this paper
• Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis.

  2015cites this paper
• Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity.

  2015cites this paper
• Interventions for induction of mucosal healing in ulcerative colitis

  2014cites this paper
• Interventions for maintenance of mucosal healing in ulcerative colitis

  2014cites this paper
• Évolution après colectomie subtotale au cours des maladies inflammatoires chroniques intestinales de l'enfant

  2014cites this paper
• Ulcerative colitis on treatment presenting with intestinal obstruction secondary to tuberculosis Case Report

  2014cites this paper
• The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature

  2013cites this paper
• Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines – is there a problem?

  2013cites this paper
• History of and current issues affecting surgery for pediatric ulcerative colitis

  2013cites this paper
• Neutrophil–Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis

  2013cites this paper
• Chapter 73 – Inflammatory Bowel Disease

  2013cites this paper
• SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF MESALAMINE AND PREDNISOLONE IN COMBINED ORAL DOSAGE FORM

  2012cites this paper
• Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements

  2012cites this paper
• Differential Diagnosis of Inflammatory Bowel Disease: What Is the Role of Colonoscopy?

  2012cites this paper
• [Infection frequency in patients with chronic idiopathic ulcerative colitis].

  2012cites this paper
• Crucial steps in the natural history of inflammatory bowel disease.

  2012cites this paper
• Impending megacolon: small bowel distension as a predictor of toxic megacolon in ulcerative colitis

  2012cites this paper
• Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis.

  2012cites this paper
• Pharmacogenomics of Inflammatory Bowel Diseases

  2012cites this paper
• Megacólon tóxico como forma de apresentação de colite ulcerosa grave: um desafio clínico

  2012cites this paper
• 143 – Inflammatory Bowel Disease

  2012cites this paper
• Serum leucine‐rich alpha‐2 glycoprotein is a disease activity biomarker in ulcerative colitis

  2012cites this paper
• Acute severe ulcerative colitis in children: A systematic review

  2011cites this paper
• When Is Surgery Indicated in Ulcerative Colitis

  2011cites this paper
• Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease

  2011cites this paper
• Advances in ulcerative colitis therapy

  2009cites this paper
• Ciclosporina oral en microemulsión para el tratamiento de la colitis ulcerativa crónica idiopática grave refractaria a esteroides intravenosos; experiencia en dos casos

  2009cites this paper
• Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy.

  2009cites this paper
• Treatment of fulminant ulcerative colitis with cyclosporine A

  2009cites this paper
• Interleukin-18 serum levels in inflammatory bowel diseases: correlation with disease activity and inflammatory markers.

  2009cites this paper
• An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume

  2009cites this paper
• Historical evolution of the management of severe ulcerative colitis.

  2008cites this paper
• INFLAMMATORY BOWEL DISEASE AND TOXIC MEGACOLON

  2008influential citation
• Nutzen und Risiken der Immunsuppression bei chronisch entzündlichen Darmerkrankungen

  2008cites this paper
• Ulcerative and Granulomatous Colitis: Idiopathic Inflammatory Bowel Disease

  2008cites this paper
• DEVELOPMENT, EVALUATION AND APPLICATION OF A PEDIATRIC ULCERATIVE COLITIS ACTIVITY INDEX (PUCAI)

  2008cites this paper
• History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis

  2008cites this paper
• Acute and chronic megacolon

  2007cites this paper
• Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy

  2007cites this paper
• Chronisch-entzündliche Darmerkrankungen - Konservative und postoperative Therapie

  2007cites this paper
• Clinical and Experimental Gastroenterology Dovepress

  year unknowncites this paper